beta blocker: be given after mi

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be given after mi 1.00

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.61
Similarity weight: 1.00
Evidence: 0.32
Plausible(beta blocker, be given after mi) ⋁
Evidence: 0.57
¬ Salient(beta blocker, be given after mi)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.57
Salient(beta blocker, be given after mi) ⋁
Evidence: 0.08
¬ Typical(beta blocker, be given after mi) ⋁
Evidence: 0.95
¬ Remarkable(beta blocker, be given after mi)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.32
Plausible(beta blocker, be given after mi) ⋁
Evidence: 0.08
¬ Typical(beta blocker, be given after mi)